Monday, January 14, 2013

Wonder why!

Study shows drugmakers suffer decline in trust

The overall corporate reputation of pharmaceutical companies declined in 2012 compared to 2011, according to an independent study by patients' organisations.

The study - "The corporate reputation of pharma in 2012: the patient perspective" - is funded by PatientView, which represents 600 patient groups.

PatientView has focused on patients' impressions on the corporate reputation of 29 individual pharmaceutical companies, and the industry as a whole, in the study that was conducted from mid-November to mid-December.

Only 34% of the 600 patient groups responding to the 2012 survey state that multinational drug companies had an “excellent” or “good” reputation during 2012. In 2011 that figure was 42%.

Forty percent of the patient groups also state that the reputation of the pharmaceutical industry declined during 2012. As many as half of the 600 respondent patient groups say that industry had a “poor” record in 2012 for having fair pricing policies or for being transparent.

No comments: